• Ensartinib shows promise in ALK-positive lung cancer

    10 monthes ago - By Healio

    CHICAGO - Ensartinib appeared safe and effective in patients with anaplastic lymphoma kinase-positive non-small cell lung cancer, according to study results presented at International Association for the Study of Lung Cancer Multidisciplinary Symposium in Thoracic Oncology.Ensartinib - a novel, potent anaplastic lymphoma kinase small molecule tyrosine kinase inhibitor - has demonstrated antitumor activity in patients who previously received a second-generation ALK TKI.
    Read more ...


  • Natural molecule appears to shut off cancer cells' energy source

    10 monthes ago - By ScienceDaily

    Researchers have not only untangled an unusual wiring system that cancer cells use for carbohydrate metabolism, but also identified a natural compound that appears to selectively shut down this system in laboratory studies.
    Read more ...